)
Medicenna Therapeutics (MDNA) investor relations material
Medicenna Therapeutics Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Reported updated clinical data for MDNA11 and bizaxofusp, with strong efficacy in multiple solid tumors and recurrent glioblastoma, respectively.
Advanced MDNA113 through preclinical studies, targeting a first-in-human trial in H2 2026.
Announced changes to the Board of Directors, with two new appointments following a retirement.
Financial highlights
Ended the quarter with $10.6 million in cash and cash equivalents, expected to fund operations into Q3 2026.
Operating costs for the quarter were $5.6 million, up from $5.1 million year-over-year, mainly due to increased R&D expenses.
Net loss for the quarter was $4.4 million ($0.05 per share), an improvement from $5.2 million ($0.07 per share) in the prior year, driven by a gain on derivative warrant liability.
R&D expenses rose to $4.1 million from $3.6 million year-over-year, reflecting expanded clinical activities.
G&A expenses remained stable at $1.5 million year-over-year.
Outlook and guidance
Cash runway projected into Q3 2026 based on current operating plan.
Plans to file an IND for MDNA113 and arrange an End of Phase 1 meeting with the FDA for MDNA11 in 2026.
Interim data from the NEO-CYT trial and updated ABILITY-1 results expected in H2 2026.
Next Medicenna Therapeutics earnings date
Next Medicenna Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)